Combinatorial library methodology applied to cancer and protease targets. Thiazolidinone derivatives targeting drug-resistant lung cancer cells

Drug Discovery Today

Volumn 13, Issue 23-24, 2008, Pages 1107-1108

  Edwards, Paul J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTINEOPLASTIC AGENT; CHYMOTRYPSIN; OCTAPEPTIDE; PACLITAXEL; PEPSIN A; PEPTIDE LIBRARY; PROTEINASE; PROTEINASE INHIBITOR; SUBTILISIN; THIAZOLIDINE DERIVATIVE; TRYPSIN;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER RESISTANCE; DRUG SCREENING; DRUG SENSITIVITY; DRUG TARGETING; ENZYME SUBSTRATE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MULTIDRUG RESISTANCE; PHARMACOPHORE; SHORT SURVEY; STAINING;

EID: 55849088363     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.10.004     Document Type: Short Survey

References (13)

1. Green D.R., and Evan G.I. A matter of life and death. Cancer Cell 1 (2002) 19-30
2. Kaelin W.G. The concept of synthetic lethality in the context of anticancer therapy. Nat. Rev. Cancer 5 (2005) 689-698
3. Gottesman M., et al. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2 (2002) 48-58
4. Ottana R., et al. 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents. Bioorg. Med. Chem. 13 (2005) 4243-4252
5. Kalaiya S.B., and Parikh A.R. Studies on 4-thiazolidinones-preparation and antimicrobial activity of R-phenyl-2-(2′,5′-dihydroxy-3′-bromophenyl)-3-aryl-5-c arboxymethyl-4-thiazolidinones, R-methyl-2-(2′-hydroxy-3′-nitro-5′-benzyl)-3-aryl-5-ca rboxymethyl-4-thiazolidinones and R-methyl-2-(2′-hydroxy-3′-nitro-5′-chlorophenyl)-3-ary l-5-carboxymethyl-4-thizaolidinones. J. Indian Chem. Soc. 64 (1987) 172-175
6. Zhou H., et al. Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells. J. Med. Chem. 51 (2008) 1242-1251
7. Lipinski C.A., et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23 (1997) 3-25
8. Diamond S.L. Methods for mapping protease specificity. Curr. Opin. Chem. Biol. 11 (2007) 46-51
9. Sheppeck J.E., et al. Synthesis of a statistically exhaustive fluorescent peptide substrate library for profiling protease specificity. Bioorg. Med. Chem. Lett. 10 (2000) 2639-2642
10. Meldal M., et al. Portion-mixing peptide libraries of quenched fluorogenic substrates for complete subsite mapping of endoprotease specificity. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3314-3318
11. Bogyo M., et al. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. Chem. Biol. 7 (2000) 27-38
12. Kofoed J., and Reymond J.-L. Identification of protease substrates by combinatorial profiling on TentaGel beads. Chem. Commun. (2007) 4453-4455
13. Kress J., et al. Enzyme accessibility and solid supports: which molecular weight enzymes can be used on solid supports? An investigation using confocal Raman microscopy. Chem. Eur. J. 8 (2002) 3769-3772